Generating a Preclinical Model for PITPNM3 and Evaluating Genotype-Phenotype Concordance: Insights from a Mouse Model

Aykut Demirkol1,2,3, Joanne Li4, Stephen H Tsang1,2,3,5,6

  • 1Jonas Children's Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory, Institute of Human Nutrition, Columbia Stem Cell Initiative, New York, NY 10032, USA.

Cells
|October 28, 2025
PubMed
Summary

Researchers developed a mouse model for PITPNM3-related retinal disease. The model showed functional deficits but lacked severe structural changes, indicating differences from human conditions and the need for further study.